VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
---|---|---|---|---|---|---|---|---|
TVIS44022085 | HTLV-1 | ENSG00000198829.6 | protein_coding | SUCNR1 | No | No | 56670 | Q9BXA5 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
Gene | SUCNR1 |
---|---|
DrugBank ID | DB00139 |
Drug Name | Succinic acid |
Target ID | BE0002258 |
UniProt ID | Q9BXA5 |
Regulation Type | |
PubMed IDs | 17192395 |
Citations | Macaulay IC, Tijssen MR, Thijssen-Timmer DC, Gusnanto A, Steward M, Burns P, Langford CF, Ellis PD, Dudbridge F, Zwaginga JJ, Watkins NA, van der Schoot CE, Ouwehand WH: Comparative gene expression profiling of in vitro differentiated megakaryocytes and erythroblasts identifies novel activatory and inhibitory platelet membrane proteins. Blood. 2007 Apr 15;109(8):3260-9. Epub 2006 Dec 27. |
Groups | Approved; Nutraceutical |
Direct Classification | Dicarboxylic acids and derivatives |
SMILES | OC(=O)CCC(O)=O |
Pathways | Mitochondrial Complex II Deficiency; 3-Methylglutaconic Aciduria Type III; 2-Ketoglutarate Dehydrogenase Complex Deficiency; 4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency; Oxidation of Branched-Chain Fatty Acids; Isovaleric Aciduria; Warburg Effect; Refsum Disease; Isobutyryl-CoA Dehydrogenase Deficiency; Propionic Acidemia; 2-Hydroxyglutric Aciduria (D and L Form); Hyperornithinemia-Hyperammonemia-Homocitrullinuria [HHH-syndrome]; 3-Methylcrotonyl-CoA Carboxylase Deficiency Type I; Congenital Lactic Acidosis; 3-Hydroxy-3-methylglutaryl-CoA Lyase Deficiency; Fumarase Deficiency; Succinic Semialdehyde Dehydrogenase Deficiency; Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency); Prolidase Deficiency (PD); Creatine Deficiency, Guanidinoacetate Methyltransferase Deficiency; Methylmalonic Aciduria; 3-Methylglutaconic Aciduria Type IV; Ornithine Aminotransferase Deficiency (OAT Deficiency); Ketone Body Metabolism; Homocarnosinosis; Methylmalonate Semialdehyde Dehydrogenase Deficiency; Prolinemia Type II; The Oncogenic Action of 2-Hydroxyglutarate; Valine, Leucine, and Isoleucine Degradation; Maple Syrup Urine Disease |
PharmGKB | PA164747739 |
ChEMBL | CHEMBL576 |